Page last updated: 2024-10-25

damnacanthal and Breast Cancer

damnacanthal has been researched along with Breast Cancer in 2 studies

damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity

Research Excerpts

ExcerptRelevanceReference
"Damnacanthal has low water solubility and low bioavailability."5.51Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies. ( Abdul Latif, AZ; Ariff, TM; Mohamad, N; Mohamed, A; Mohd, MR; Suffian, IFM; Wan Nik, WMN, 2019)
"Damnacanthal has low water solubility and low bioavailability."1.51Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies. ( Abdul Latif, AZ; Ariff, TM; Mohamad, N; Mohamed, A; Mohd, MR; Suffian, IFM; Wan Nik, WMN, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohd, MR1
Ariff, TM1
Mohamad, N1
Abdul Latif, AZ1
Wan Nik, WMN1
Mohamed, A1
Suffian, IFM1
Aziz, MY1
Abu, N1
Yeap, SK1
Ho, WY1
Omar, AR1
Ismail, NH1
Ahmad, S1
Pirozyan, MR1
Akhtar, NM1
Alitheen, NB1

Other Studies

2 other studies available for damnacanthal and Breast Cancer

ArticleYear
Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies.
    Pakistan journal of pharmaceutical sciences, 2019, Volume: 32, Issue:5

    Topics: Anthraquinones; Antineoplastic Agents; Antioxidants; Biodegradable Plastics; Breast Neoplasms; Delay

2019
Combinatorial Cytotoxic Effects of Damnacanthal and Doxorubicin against Human Breast Cancer MCF-7 Cells in Vitro.
    Molecules (Basel, Switzerland), 2016, Sep-14, Volume: 21, Issue:9

    Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug

2016